Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex Asia Holdings LTD., it has signed an agreement to purchase Vectura Group Limited (Vectura) from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International (PMI) (NYSE: PM). Vectura is a leader in inhalation drug device design and formulation, based in Chippenham, United Kingdom.
Read the full article: Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation //
Source: https://www.businesswire.com/news/home/20240916819174/en/Molex-a-Parent-to-Phillips-Medisize-Announces-Agreement-to-Acquire-the-Vectura-Group-Limited-Expanding-Its-Drug-Delivery-Capabilities-in-Inhalation